Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

IMPORTANCE: Immune-related adverse events (irAEs) have been associated with the efficacy of PD-1 (programmed cell death protein 1) inhibitors in patients with melanoma, but whether such an association exists for non–small-cell lung cancer (NSCLC) has remained unknown. OBJECTIVE: To evaluate the rela...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JAMA Oncol
Egile Nagusiak: Haratani, Koji, Hayashi, Hidetoshi, Chiba, Yasutaka, Kudo, Keita, Yonesaka, Kimio, Kato, Ryoji, Kaneda, Hiroyasu, Hasegawa, Yoshikazu, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Medical Association 2017
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583041/
https://ncbi.nlm.nih.gov/pubmed/28975219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.2925
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak